
Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Global Forecast 2024-2030
Description
Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Global Forecast 2024-2030
The Immunofluorescence Assay Market size was estimated at USD 3.98 billion in 2023 and expected to reach USD 4.14 billion in 2024, at a CAGR 5.51% to reach USD 5.80 billion by 2030.
Global Immunofluorescence Assay Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Immunofluorescence Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunofluorescence Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Immunofluorescence Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, AESKU.GROUP GmbH & Co. KG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cell Signaling Technology, Inc., Cellabs, Elabscience Biotechnology Inc., Enzo Biochem, Inc., J. Mitra & Co. Pvt. Ltd., Maravai LifeSciences Inc., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Zyagen, Inc..
Market Segmentation & Coverage
This research report categorizes the Immunofluorescence Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:
Products
Antibodies
Consumables & Accessories
Instruments
Kits
Reagents
Type
Direct Immunofluorescence
Indirect Immunofluorescence
Disease
Autoimmune Diseases
Cancer
Cardiovascular Diseases
Infectious Diseases
End-User
Academic & Research Institutes
Contract Research Organizations
Hospitals & Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Immunofluorescence Assay Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunofluorescence Assay Market?
3. What are the technology trends and regulatory frameworks in the Immunofluorescence Assay Market?
4. What is the market share of the leading vendors in the Immunofluorescence Assay Market?
5. Which modes and strategic moves are suitable for entering the Immunofluorescence Assay Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
196 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Immunofluorescence Assay Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of chronic disease across the world
- 5.1.1.2. Increasing government support by providing funds and budget in cancer diagnostics improvement
- 5.1.1.3. Growing awareness of early detection and treatment of cancer
- 5.1.2. Restraints
- 5.1.2.1. Concern associated with quality research of antibodies and high instrumental cost
- 5.1.3. Opportunities
- 5.1.3.1. Increasing product approvals and favorable reimbursements
- 5.1.3.2. Introduction of modern methods to use immunofluorescence assay
- 5.1.4. Challenges
- 5.1.4.1. Dearth of skilled healthcare professionals globally
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Immunofluorescence Assay Market, by Products
- 6.1. Introduction
- 6.2. Antibodies
- 6.3. Consumables & Accessories
- 6.4. Instruments
- 6.5. Kits
- 6.6. Reagents
- 7. Immunofluorescence Assay Market, by Type
- 7.1. Introduction
- 7.2. Direct Immunofluorescence
- 7.3. Indirect Immunofluorescence
- 8. Immunofluorescence Assay Market, by Disease
- 8.1. Introduction
- 8.2. Autoimmune Diseases
- 8.3. Cancer
- 8.4. Cardiovascular Diseases
- 8.5. Infectious Diseases
- 9. Immunofluorescence Assay Market, by End-User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Contract Research Organizations
- 9.4. Hospitals & Diagnostic Centers
- 9.5. Pharmaceutical & Biotechnology Companies
- 10. Americas Immunofluorescence Assay Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Immunofluorescence Assay Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.
- 10. South Korea
- 11.
- 11. Taiwan
- 11.
- 12. Thailand
- 11.
- 13. Vietnam
- 12. Europe, Middle East & Africa Immunofluorescence Assay Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.
- 10. Nigeria
- 12.
- 11. Norway
- 12.
- 12. Poland
- 12.
- 13. Qatar
- 12.
- 14. Russia
- 12.
- 15. Saudi Arabia
- 12.
- 16. South Africa
- 12.
- 17. Spain
- 12.
- 18. Sweden
- 12.
- 19. Switzerland
- 12.
- 20. Turkey
- 12.
- 21. United Arab Emirates
- 12.
- 22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abnova Corporation
- 14.1.2. AESKU.GROUP GmbH & Co. KG
- 14.1.3. Becton, Dickinson and Company
- 14.1.4. Bio-Rad Laboratories, Inc.
- 14.1.5. Bruker Corporation
- 14.1.6. Cell Signaling Technology, Inc.
- 14.1.7. Cellabs
- 14.1.8. Elabscience Biotechnology Inc.
- 14.1.9. Enzo Biochem, Inc.
- 14.1.
- 10. J. Mitra & Co. Pvt. Ltd.
- 14.1.
- 11. Maravai LifeSciences Inc.
- 14.1.
- 12. Merck KGaA
- 14.1.
- 13. Olympus Corporation
- 14.1.
- 14. PerkinElmer Inc.
- 14.1.
- 15. Thermo Fisher Scientific, Inc.
- 14.1.
- 16. Zyagen, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. IMMUNOFLUORESCENCE ASSAY MARKET RESEARCH PROCESS
- FIGURE 2. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2023 VS 2030
- FIGURE 3. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. IMMUNOFLUORESCENCE ASSAY MARKET DYNAMICS
- FIGURE 7. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
- FIGURE 8. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
- FIGURE 12. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. IMMUNOFLUORESCENCE ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. IMMUNOFLUORESCENCE ASSAY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.